Leading Infectious Disease Biomaterial Manufacturer

  • Copan FLOQSwab® and Liquid Control Products
    • Clinical Diagnostics,
    • Proficiency Programs,
    • Training, Verification and Development
  • Antigens for Diagnostic Test Manufacturers
  • Viral Transport Medium – DxTM™

Microbix’s Virtual AGM 2024

Microbix will be hosting a virtual AGM on March 27, 2024, at 1:00 pm. The online link will allow shareholders to listen to the AGM and view a CEO...

Microbix Reports Record Results for Q1 Fiscal 2024

Record Revenues of $8.4 million and Record Net Income of $2.5 million MISSISSAUGA, CANADA, February 14, 2024 - Microbix Biosystems Inc. (TSX: MBX,...

Microbix Schedules Release of Results for Q1 Fiscal 2024

Results Release and Webinar Discussion on Morning of February 14, 2024 MISSISSAUGA, CANADA, February 7, 2024 - Microbix Biosystems Inc. (TSX: MBX,...


Why choose Microbix Quality Assessment Products (QAPs)? Find out more.


Microbix produces one of the world’s broadest range of infectious disease antigens.


Microbix has a partnership opportunity. Check it out here.

Our Commitment to Quality

Our quality process ensures our customers receive products that meet and exceed their needs and expectations. Our quality management system takes into consideration regulatory requirements that are applicable to the type of products we manufacture and the industries we serve.